Clinical presentation of parvovirus B19 infection in children with aplastic crisis

Richard Kellermayer1, Howard Faden, Mauro Grossi

  • 1School of Medicine and Biomedical Sciences, State University of New York at Buffalo, The Children's Hospital of Buffalo, USA.

Insights

Parvovirus B19 causes aplastic crisis in children with sickle cell disease or hereditary spherocytosis. These children present with fever and delayed recovery, differing from typical parvovirus B19 infections.

Area of Science:

  • Pediatrics
  • Hematology
  • Infectious Diseases

Background:

  • Parvovirus B19 is a common cause of aplastic crisis.
  • Children with underlying hemoglobinopathies or red blood cell disorders are at higher risk.

Purpose of the Study:

  • To describe the clinical presentation and course of parvovirus B19-induced aplastic crisis in children with sickle cell hemoglobinopathies and hereditary spherocytosis.
  • To compare the presentation of parvovirus B19 infection in these children to that in normal children.

Main Methods:

  • Retrospective review of medical records of 22 children with parvovirus B19-induced aplastic crisis.
  • Analysis of patient demographics, symptoms, time to hospital presentation, and laboratory findings.

Main Results:

  • The study included 16 children with sickle cell hemoglobinopathies and 6 with hereditary spherocytosis.
  • Fever was the most common symptom (73%). Rash was absent in both groups.
  • Children with sickle cell disease presented earlier (mean 1.4 days) than those with hereditary spherocytosis (mean 5 days; P = 0.02).
  • Reticulocyte counts and parvovirus B19-specific IgG antibodies rose approximately 1 week after illness onset.

Conclusions:

  • Parvovirus B19 infection in children with sickle cell hemoglobinopathies and hereditary spherocytosis presents differently than in healthy children.
  • Fever is a prominent symptom, and rash is notably absent.
  • Delayed recovery is indicated by the timing of reticulocyte count and antibody rise.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...